Effects of nano and conventional Zinc Oxide on anxiety-like behavior in male rats

Indian Journal of Pharmacology

Volumn 45, Issue 5, 2013, Pages 508-512

  Torabi, Mozhgan ^a   Kesmati, Mahnaz ^a   Harooni, Hooman Eshagh ^a   Varzi, Hosein Najafzadeh ^a  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Anxiety; Nano ZnO; plus maze; rat

Indexed keywords

ANXIOLYTIC AGENT; UNCLASSIFIED DRUG; ZINC; ZINC OXIDE; ZINC OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BLOOD PH; CONTROLLED STUDY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PARTICLE SIZE; RAT; TRANQUILIZING ACTIVITY; ZINC BLOOD LEVEL;

ANXIETY; NANO ZNO; PLUS MAZE; RAT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; HYDROGEN-ION CONCENTRATION; MALE; METAL NANOPARTICLES; RATS; RATS, WISTAR; ZINC; ZINC OXIDE;

EID: 84884546173     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.117784     Document Type: Article

References (25)

1. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatr 2005;62:617-27
2. Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, et al. Depression and generalized anxiety disorder: Cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatr 2007; 64:651-60
3. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Rev 2000;34:137-48
4. Magistretti J, Castelli L, Taglietti V, Tanzi F. Dual effect of Zn2+ on multiple types of voltage-dependent Ca2+ currents in rat palaeocortical neurons. Neuroscience 2003;117:249-64
5. Prasad AS. Discovery of human zinc deficiency: 50 years later. J Trace Elem Med Biol 2012;26:66-9
6. Tassabehji NM, Corniola RS, Alshingiti A, Levenson CW. Zinc deficiency induces depression-like symptoms in adult rats. Physiol Behav 2008;95:365-9
7. Whittle N, Lubec G, Singewald N. Zinc deficiency induces enhanced depressionlike behaviour and altered limbic activation reversed by antidepressant treatment in mice. Amino Acids 2009;36:147-58
8. Sobhanirad S, Valizade R, Moghimi A, Tahmasebi A. Evaluation the a anexiolytic effects of Zinc supplemental Diet in the Elevated Plus-Maze Test. Res J Biol Sci 2008;3:964-7
9. Edwards HM, BakerDH. Bioavailability of Zinc in several sources of zinc oxide, zinc sulfate, and zinc metal. J Anim Sci 1999;77:2730-5
10. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007;97:163-80
11. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at nano level. Science 2006;311:622-7
12. Jin T, Sun D, Su JY, Zhang H, Sue HJ. Antimicrobial efficacy of zinc oxide quantum dots against Listeria monocytogenes, Salmonella enteritidis, and Escherichia coli O157:H7. J Food Sci 2009;74:M46-52
13. Yan L, Zhao F, Li SJ, Hu ZB, Zhao YL. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes and graphenes. Nanoscale 2011;3:362-82
14. Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010;7:1063-77
15. Wang HJ, Growcock AC, Tang TH, Hara JO, Huang YW, Aronstam RS. Zinc oxide nanoparticle disruption of store-operated calcium entry in a muscarinic receptor signalling pathway. Toxicol In Vitro 2010;24:1953-61
16. Mardsoltani M, Kesmati M, Khajehpour L, Rasekh A, Shamshirgarzadeh A. Interaction between anxiolytic effect of testosterone and ß-1 adrenoceptors of basolateral amygdala. Int J Pharmacol 2012;8:344-54
17. Sonavane G, Tomoda K, Makino K. Bio distribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids Surf B Biointerfaces 2008;66:274-80
18. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: The need of the hour. Toxicol Appl Pharmacol 2012;258:151-65
19. Decuzzi P, Causa F, Ferrari M, Netti PA. The effective dispersion of nanovectors within the tumor microvasculature. Ann Biomed Eng 2006;34:633-41
20. Takeda A, Tamano H. Insight into zinc signalling from dietary zinc deficiency. Brain Res Rev 2009;62:33-44
21. Bergink V, Van Megen HJ, Westenberg HG. Glutamate and anxiety. Eur Neuropsychopharmacol 2004;14:175-83
22. Xie Z, Commissaris L. Anxiolytic-like effects of the noncompetitive NMDA antagonist MK801. Pharmacol Biochem Behav 1992;43:471-7
23. Koh JY, Choi DW. Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-D-aspartate receptors. Neuroscience 1994;60:1049-57
24. Li YV, Hough CJ, Sarvey JM. Do we need zinc to think? Sci STKE 2003;182:19
25. Takeda A, Minami A, Seki Y, Oku N. Differential effects of zinc on glutamatergic and GABAergic neurotransmitter systems in the hippocampus. J Neurosci Res 2004;75:225-9